09Oct

Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

Alpha Laboratories Ltd. (Eastleigh, UK) is delighted to have been appointed as the exclusive distributor for Arquer Diagnostics Ltd (“Arquer”) in the UK and Republic of Ireland. Arquer (Sunderland, UK) is an in-vitro diagnostic company developing breakthrough diagnostic tests for the detection of bladder and prostate cancer. Its non-invasive cancer diagnostic tests are based on the MCM5 (minichromosome maintenance protein) platform. The first Arquer product is ADXBLADDER, a bladder cancer diagnostic test, and a number of clinical trials are running to validate many other indications. 

Michelle Holland, Alpha Laboratories’ Diagnostics Sales and Marketing director says, “Arquer shares the Alpha Laboratories’ vision to provide innovative diagnostic pathways that enhance patient care and improve outcomes, whilst reducing overall healthcare costs. We welcome this partnership to expand our specialist diagnostics portfolio into this important clinical area.

One of the key elements of the success of any product launch is the quality of the technical and scientific support delivered to all stakeholders. I am extremely excited about the partnership with Alpha Laboratories, as they have an incredible track record of success and a reputation in the IVD field. The Arquer Diagnostics’ Team and I look forward to many years of success together with Alpha Laboratories”, says Nadia Whittley, Arquer CEO.

For further information please contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk 

Related

NEW TEST COULD REVOLUTIONISE THE DIAGNOSIS OF ‘SUPERBUGS’

A new exhibition at the Science Museum, London will feature an invention from the Oxford area which ...

Read More >

Genedrive Receives NHS Grant

The UK NHS National Institute for Health Research in June 2018 have offered Professor Bill Newman an...

Read More >

Protect Your Samples from Acidification When Shipped On Dry Ice

The new ProtectR® tubes, now available from Alpha Laboratories, have the only container closure syst...

Read More >

MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated I...

Read More >

Idris Oncology one of first companies to receive free human tissue through Codex4SME’s

The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive h...

Read More >